I+A

SAVE THE DATE: 19 May 2010-Moving beyond the EWG: Charting a new path for WHO to promote innovation AND access to medicines

Moving beyond the EWG: Charting a new path for WHO to promote innovation AND access to medicines

Non-governmental organization perspectives on de-linkage, prizes and the R+D Treaty

Date: Wednesday, 19 May 2010
Location: Salle XXV, Palais des Nations
Time: 13:00 to 14:30

I+A: Innovation+Access

Program and Agenda, Roundtable on Prizes

Written by James Love
Wednesday, 07 January 2009

 Program and Agenda

(Draft 7Jan09)

Roundtable on De-linking R&D Incentives from Prices

Designing Innovation Inducement Prizes for Diagnostics, New Drugs and Vaccines for Type II and III diseases and conditions, with a particular focus on TB and Chagas Disease

 

KEI comments to IGWG2

Written by Judit Rius Sanjuan
Friday, 09 November 2007

KEI comments to IGWG2

8 November 2007

KEI appreciates the opportunity to speak today. Our comments will focus on 3 items.

1. Transparency

WHO IGWG (Spanish)

Written by Judit Rius Sanjuan
Wednesday, 23 May 2007


Informe de KEI

Comments on the IGWG II bis

Thiru Balasubramaniam, Geneva Representative, Knowledge Ecology International 

Sara Crager, MD/PhD Candidate '12 at Yale University/Universities Allied for Essential Medicines

Nicoletta Dentico, Policy and Advocacy Advisor, DNDi

Working Document Proposed by Barbados and Bolivia

Written by Malini Aisola
Saturday, 26 April 2008

Link to document.

April 2008 

According to resolution WHA60.30 on Public Health, Innovation and Intellectual Property, the
Director-General of the WHO is asked:

The World Health Assembly takes step back, but leaves door open, for medical R&D Treaty

This morning the 62nd session World Health Assembly agreed to a resolution on public health, innovation and intellectual property that, among other things, settled outstanding issues regarding the “stakeholders” for various parts of the Global Strategy and Plan of Action. (GS/PoA). With regard to the issue of a possible medical R&D treaty, the outcome of the negotiation was something of a split decision. On the one hand, the WHA agreed that the WHO would not be a stakeholder, in terms of the specific element of the WHO Global Strategy document.

WHA: Statement by the Government of Bolivia

This is the statement that the government of Bolivia delivered today to the 62nd World Health Assembly at the conclusion of the discussions on the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (WHA 61.21).

Statement of Bolivia on resolving outstanding elements of agenda item 12.8

Joint Statement on behalf of

Bangladesh, Barbados, Bolivia and Suriname, and
Cuba, Ecuador, Nicaragua and Venezuela

WHO at a crossroads on a mandate for an R&D Treaty

21 May 2009

Today at the World Health Assembly (WHA) the US and EU are opposing that the WHO have a mandate on global research and development norms, including the possibility for Member States to negotiate at WHO a global biomedical R&D treaty.

Developing countries governments made very strong interventions this morning on this issue (among them India, Bolivia, Barbados, Suriname, Bangladesh, Ghana, Argentina, Venezuela, Nicaragua, Ecuador, Cuba and Jamaica) and are wondering where are the promises of multilateralism made by the new Obama administration.

Divide and rule at the WHO?

Thursday, 21 May 2009

Delegates at the World Health Assembly will have to grapple with how best to deploy their delegations to simultaneously cover pandemic influenza and resolving the outstanding elements of the WHO IGWG Plan of Action.

Today’s WHO Journal lists the following morning schedule for Committee A.

Item 11 (continued) Medium-strategic plan, including Proposed Programme budget 2010-2011

To consider appropriation resolution for financial period 2010-2011

Item 12 (continued) Technical and health matters

Syndicate content